ACLX Arcellx Inc
ACLX Arcellx Inc
Healthcare · Biotechnology
Market read
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
ACLX Price Structure
Loading chart…
Loading timeframes…
News (last pull)
Headlines about ACLX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 67 days ago · Jun 12
- Arcellx Director Sells 6,000 Shares for $450,000
- UBS Initiates Coverage of Arcellx With Bullish Outlook as Biotech Fundamentals Inflect
- Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
- Legend Biotech Arcellx rise after FDA draft guidance on multiple myeloma trials
- Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue to Soar?
ACLX research tape
9 dated scans, research, and events, newest first — the full record.
Types